Cell Cycle Inhibitors in Cancer Therapy: Current Strategies - Cancer Drug Discovery and Development (Hardback)
  • Cell Cycle Inhibitors in Cancer Therapy: Current Strategies - Cancer Drug Discovery and Development (Hardback)
zoom

Cell Cycle Inhibitors in Cancer Therapy: Current Strategies - Cancer Drug Discovery and Development (Hardback)

(editor), (editor)
£179.99
Hardback 326 Pages / Published: 20/11/2002
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket
Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases. Topics range from Cdk inhibitors and cell cycle regulators to the prognostic value of p27 and tumor suppressor genes as diagnostic tools. Actual case studies show how the new molecular understanding has produced such drugs as Flavopiridol and Sulindac. The book brings all the recent critical research findings to bear on clinical practice, and clearly shows their powerful impact on the diagnostics, prognostics, and therapeutics of cancer, AIDS, and cardiovascular disease.

Publisher: Humana Press Inc.
ISBN: 9780896039308
Number of pages: 326
Weight: 654 g
Dimensions: 235 x 155 x 20 mm
Edition: 2003 ed.

You may also be interested in...

The Emperor of All Maladies
Added to basket
Nature's Cancer-Fighting Foods
Added to basket
Laws of Medicine
Added to basket
The Cancer Survivor's Companion
Added to basket
The Biology of Cancer
Added to basket
B is for Breast Cancer
Added to basket
Radical Remission
Added to basket
Oxford Handbook of Oncology
Added to basket
£34.99
Part-work (fascículo)
Mum's Not Having Chemo
Added to basket
Cancer: A Very Short Introduction
Added to basket
Medicine Hands
Added to basket
£29.99
Paperback
The End of Your Life Book Club
Added to basket
Cancer Care
Added to basket
£7.99
Paperback

Reviews

Please sign in to write a review

Your review has been submitted successfully.